An FDA News Release reports of a nationwide voluntary recall of all non-expired sterile drugs distributed by Abrams Royal Compounding Pharmacy. The Dallas company is recalling all intravenous injections, injectable medication, eye drops, nasal sprays, pellet implants, inhalation solutions, and eye ointments made between June 17th and December 17th 2013.
The FDA is alerting all health care professionals to stop using affected products as they may cause serious ...
continue reading...The FDA is advising all consumers to stop using the dietary supplement called “Mass Destruction” due to the presence of dangerous synthetic steroids. An FDA News Release reports that this product contains anabolic steroids and has been linked to at least one serious illness. Mass Destruction is manufactured for Blunt Force Nutrition and the FDA is now attempting to identify the product’s manufacturer.
The North Carolina Department of Health and Human Services reports of a ...
continue reading...State and federal prosecutors are pursuing a lawsuit against Novartis Pharmaceuticals Corp. for paying kickbacks to BioScrip pharmacy. A story in The Wall Street Journal reports that Novartis incentivized BioScrip to recommend refills of its blood transfusion drug, Exjade.
In order to boost sales of Exjade, Novartis provided referrals and rebates to the specialty pharmacy. BioScrip encouraged refills for patients who may not have needed it in exchange for these kickbacks. Exjade is an ...
continue reading...
The American Cancer Society says different forms of surgery might be used to treat some forms of mesothelioma.
Major surgery might be needed to attempt a cure – or at least extend the patient’s life — if he or she is otherwise in good health and the tumor appears to be in only one place. In most cases, though, the cancer has spread to other places before it is found and ...
continue reading...A Thalidomide lawsuit involving over one hundred people form Australia and New Zealand and settled according to news sources. Thalidomide was a prescription drug marketed and sold in the 1950s but was pulled from the market when it was linked to causing thousands of babies to be born with deformities. The British company Diageo, who now owns the firm that originally distributed Thalidomide, agreed to the settlement that is valued at approximately $81 million that will compensate the ...
continue reading...
